These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36802351)

  • 1. Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patients.
    Berger T; Noble DJ; Yang Z; Shelley LE; McMullan T; Bates A; Thomas S; Carruthers LJ; Beckett G; Duffton A; Paterson C; Jena R; McLaren DB; Burnet NG; Nailon WH
    Acta Oncol; 2023 Feb; 62(2):166-173. PubMed ID: 36802351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting radiotherapy-induced xerostomia in head and neck cancer patients using day-to-day kinetics of radiomics features.
    Berger T; Noble DJ; Shelley LEA; McMullan T; Bates A; Thomas S; Carruthers LJ; Beckett G; Duffton A; Paterson C; Jena R; McLaren DB; Burnet NG; Nailon WH
    Phys Imaging Radiat Oncol; 2022 Oct; 24():95-101. PubMed ID: 36386445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
    Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
    Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification.
    Pota M; Scalco E; Sanguineti G; Farneti A; Cattaneo GM; Rizzo G; Esposito M
    Artif Intell Med; 2017 Sep; 81():41-53. PubMed ID: 28325604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-radiomics features during radiotherapy improve the prediction of late xerostomia.
    van Dijk LV; Langendijk JA; Zhai TT; Vedelaar TA; Noordzij W; Steenbakkers RJHM; Sijtsema NM
    Sci Rep; 2019 Aug; 9(1):12483. PubMed ID: 31462719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia.
    van Dijk LV; Thor M; Steenbakkers RJHM; Apte A; Zhai TT; Borra R; Noordzij W; Estilo C; Lee N; Langendijk JA; Deasy JO; Sijtsema NM
    Radiother Oncol; 2018 Sep; 128(3):459-466. PubMed ID: 29958772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric changes of the parotid gland during IMRT based on mid-treatment imaging: implications for parotid stem cell sparing strategies in head and neck cancer.
    Gjini M; Ahmed S; Kalnicki S; Tomé WA; Garg MK; Kabarriti R; Brodin NP
    Acta Oncol; 2022 Sep; 61(9):1069-1074. PubMed ID: 35978529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy.
    Yang X; Tridandapani S; Beitler JJ; Yu DS; Chen Z; Kim S; Bruner DW; Curran WJ; Liu T
    Acad Radiol; 2014 Oct; 21(10):1304-13. PubMed ID: 25088832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy.
    Rosen BS; Hawkins PG; Polan DF; Balter JM; Brock KK; Kamp JD; Lockhart CM; Eisbruch A; Mierzwa ML; Ten Haken RK; El Naqa I
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1319-1329. PubMed ID: 30003997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics and dosiomics-based prediction of radiotherapy-induced xerostomia in head and neck cancer patients.
    Abdollahi H; Dehesh T; Abdalvand N; Rahmim A
    Int J Radiat Biol; 2023; 99(11):1669-1683. PubMed ID: 37171485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
    Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
    Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parotid gland mean dose as a xerostomia predictor in low-dose domains.
    Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
    Acta Oncol; 2017 Sep; 56(9):1197-1203. PubMed ID: 28502238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
    Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
    Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    van Dijk LV; Noordzij W; Brouwer CL; Boellaard R; Burgerhof JGM; Langendijk JA; Sijtsema NM; Steenbakkers RJHM
    Radiother Oncol; 2018 Jan; 126(1):89-95. PubMed ID: 28951007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomia.
    Trada Y; Lee MT; Jameson MG; Chlap P; Keall P; Moses D; Lin P; Fowler A
    Radiother Oncol; 2023 Sep; 186():109745. PubMed ID: 37330056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT.
    Wu H; Chen X; Yang X; Tao Y; Xia Y; Deng X; Zheng C; Robbins J; Schultz C; Li XA
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1308-1318. PubMed ID: 29891201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
    Nutting CM; Morden JP; Harrington KJ; Urbano TG; Bhide SA; Clark C; Miles EA; Miah AB; Newbold K; Tanay M; Adab F; Jefferies SJ; Scrase C; Yap BK; A'Hern RP; Sydenham MA; Emson M; Hall E;
    Lancet Oncol; 2011 Feb; 12(2):127-36. PubMed ID: 21236730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial.
    Buettner F; Miah AB; Gulliford SL; Hall E; Harrington KJ; Webb S; Partridge M; Nutting CM
    Radiother Oncol; 2012 Apr; 103(1):82-7. PubMed ID: 22444242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.